Previous 10 | Next 10 |
PORTLAND, Maine , Feb. 22, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve ...
PORTLAND, Maine, Feb. 16, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the he...
ImmuCell ([[ICCC]] +0.5%) expects to report total product sales of ~$15.3M (+12% Y/Y) for the FY20.Company mentions that the First Defense® product line has been exceedingly well received by the market, and has temporarily outstripped their ability to manufacture enough product...
PORTLAND, Maine, Jan. 07, 2021 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the he...
ImmuCell ([[ICCC]] -0.6%) announces restructuring of bank debt, it secured a $1.5M loan from its existing lender, Gorham Savings Bank, with a seven-year term and amortization at 3.5% per annum.Proceeds of ~$624k were used to pay down the outstanding balance on its mortgage loan with Gorham Sa...
PORTLAND, Maine, Dec. 15, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the he...
ImmuCell Corporation (ICCC) Q3 2020 Earnings Conference Call November 13, 2020, 09:00 AM ET Company Participants Joe Diaz - Lytham Partners Michael Brigham - President and CEO Conference Call Participants Sam Rebotsky - SER Asset Management Presentation Operator Good morning and welcome to th...
The following slide deck was published by ImmuCell Corporation in conjunction with their 2020 Q3 earnings call. For further details see: ImmuCell Corporation 2020 Q3 - Results - Earnings Call Presentation
ImmuCell (ICCC): Q3 GAAP EPS of -$0.04 beats by $0.04.Revenue of $3.72M (+25.3% Y/Y) beats by $0.45M.Press Release For further details see: ImmuCell EPS beats by $0.04, beats on revenue
PORTLAND, Maine, Nov. 12, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve th...
News, Short Squeeze, Breakout and More Instantly...
2024-04-17 08:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
PORTLAND, Maine, April 09, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health ...
2024-04-07 15:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...